Natural Language Processing for Public Health

Similar documents
Concise Antibiogram Toolkit Background

Understanding the Hospital Antibiogram

CUMULATIVE ANTIBIOGRAM

Antimicrobial Stewardship Strategy: Antibiograms

Aberdeen Hospital. Antibiotic Susceptibility Patterns For Commonly Isolated Organisms For 2015

Principles of Infectious Disease. Dr. Ezra Levy CSUHS PA Program

What bugs are keeping YOU up at night?

BactiReg3 Event Notes Module Page(s) 4-9 (TUL) Page 1 of 21

Vaccination as a potential strategy to combat Antimicrobial Resistance in the elderly

Advanced Practice Education Associates. Antibiotics

The UK 5-year AMR Strategy - a brief overview - Dr Berit Muller-Pebody National Infection Service Public Health England

Workshop Summary and Action Items

CONTAGIOUS COMMENTS Department of Epidemiology

General Approach to Infectious Diseases

CONTAGIOUS COMMENTS Department of Epidemiology

Antimicrobial Susceptibility Patterns

Mark Your Calendars Now! Next Event Ships: September 14, 2015

Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST

2015 Antibiotic Susceptibility Report

Antimicrobial Resistance Trends in the Province of British Columbia

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting

2016 Antibiotic Susceptibility Report

Protocol for Surveillance of Antimicrobial Resistance in Urinary Isolates in Scotland

The Nuts and Bolts of Antibiograms in Long-Term Care Facilities

Recommendations on Surveillance of Antimicrobial Resistance in Ireland

A retrospective analysis of urine culture results issued by the microbiology department, Teaching Hospital, Karapitiya

Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing

Antimicrobial Stewardship Program 2 nd Quarter

a. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.

Lab Exercise: Antibiotics- Evaluation using Kirby Bauer method.

جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی

2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine

Antibiotic Stewardship Program (ASP) CHRISTUS SETX

J of Evolution of Med and Dent Sci/ eissn , pissn / Vol. 4/ Issue 37/ May 07, 2015 Page 6443

Pathogens and Antibiotic Sensitivities in Post- Phacoemulsification Endophthalmitis, Kaiser Permanente, California,

Approach to pediatric Antibiotics

CANADIAN ANTIMICROBIAL RESISTANCE SURVEILLANCE SYSTEM

11/10/2016. Skin and Soft Tissue Infections. Disclosures. Educational Need/Practice Gap. Objectives. Case #1

2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals

QUICK REFERENCE. Pseudomonas aeruginosa. (Pseudomonas sp. Xantomonas maltophilia, Acinetobacter sp. & Flavomonas sp.)

Antimicrobial Resistance Strains

Preserve the Power of Antibiotics

What s new in EUCAST methods?

Q1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants.

BACTERIAL SUSCEPTIBILITY REPORT: 2016 (January 2016 December 2016)

Compliance of manufacturers of AST materials and devices with EUCAST guidelines

POLQM Quality Conference October 2 nd, 2017

2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services

Leveraging the Lab and Microbiology Department to Optimize Stewardship

Objectives. Antibiotic Prophylaxis in Urologic Procedures: A Review of the CUA Guidelines & Local Epidemiology of Drug Resistance

Antimicrobial Resistance Trends in the Province of British Columbia. August Epidemiology Services British Columbia Centre for Disease Control

Standing Orders for the Treatment of Outpatient Peritonitis

UNDERSTANDING YOUR DATA: THE ANTIBIOGRAM

2 0 hr. 2 hr. 4 hr. 8 hr. 10 hr. 12 hr.14 hr. 16 hr. 18 hr. 20 hr. 22 hr. 24 hr. (time)

Antimicrobial Resistance Prevention (Action Package: Prevent-1) Putting AMR on the priority list: Sweden Dr. Nils Anders Tegnell, Director, The

Surveillance of Antimicrobial Resistance and Healthcare-associated Infections in Europe

The Rise of Antibiotic Resistance: Is It Too Late?

microbiology testing services

Cipro for gram positive cocci in urine

Imagine. Multi-Drug Resistant Superbugs- What s the Big Deal? A World. Without Antibiotics. Where Simple Infections can be Life Threatening

Educating Clinical and Public Health Laboratories About Antimicrobial Resistance Challenges

9/30/2016. Dr. Janell Mayer, Pharm.D., CGP, BCPS Dr. Lindsey Votaw, Pharm.D., CGP, BCPS

Standing Orders for the Treatment of Outpatient Peritonitis

To view an archived recording of this presentation please click the following link:

Childrens Hospital Antibiogram for 2012 (Based on data from 2011)

Antimicrobial resistance at different levels of health-care services in Nepal

1. The preferred treatment option for an initial UTI episode in a 22-year-old female patient

Antimicrobial Use and Resistance in Australia

Finnzymes Oy. PathoProof Mastitis PCR Assay. Real time PCR based mastitis testing in milk monitoring programs

FIS Resistance Surveillance: The UK Landscape. Alasdair MacGowan Chair BSAC Working Party on Antimicrobial Resistance Surveillance

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

INFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER

RCH antibiotic susceptibility data

Pipestone Veterinary Services

Routine internal quality control as recommended by EUCAST Version 3.1, valid from

CONTAGIOUS COMMENTS Department of Epidemiology

IDSA GUIDELINES COMMUNITY ACQUIRED PNEUMONIA

ESCMID Online Lecture Library. by author

Antibiotic Stewardship in Nursing Homes SAM GUREVITZ PHARM D, CGP ASSOCIATE PROFESSOR BUTLER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCE

Summary of the latest data on antibiotic resistance in the European Union

2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

Implementation of a National Action Plan and International standards especially with regard to Responsible and prudent use of antimicrobials

Surveillance for Antimicrobial Resistance and Preparation of an Enhanced Antibiogram at the Local Level. janet hindler

UNDERSTANDING THE ANTIBIOGRAM

Drive More Efficient Clinical Action by Streamlining the Interpretation of Test Results

Antibiotic Susceptibility Patterns of Community-Acquired Urinary Tract Infection Isolates from Female Patients on the US (Texas)- Mexico Border

ESBL Positive E. coli and K. pneumoneae are Emerging as Major Pathogens for Urinary Tract Infection

The Search For Antibiotics BY: ASLEY, ELIANA, ISABELLA AND LUNISCHA BSC1005 LAB 4/18/2018

Validation of the PathoProof TM Mastitis PCR Assay for Bacterial Identification from Milk Recording Samples

Urban Water Security Research Alliance

Antibiotic therapy of acute gastroenteritis

EUCAST recommended strains for internal quality control

Dr Nata Menabde Executive Director World Health Organization Office at the United Nations Global action plan on antimicrobial resistance

English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR)

Combination vs Monotherapy for Gram Negative Septic Shock

Antibacterial Resistance In Wales

Bacteriology. Mycology. Genova Diagnostics Europe Parkgate House 356 West Barnes Lane New Malden, Surrey. KT3 6NB. Order Number:

Perichondritis: Source: UpToDate Ciprofloxacin 10 mg/kg/dose PO (max 500 mg/dose) BID Inpatient: Ceftazidime 50 mg/kg/dose q8 hours IV

The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards

Transcription:

Natural Language Processing for Public Health Coding OLIS Microbiology Data Kevin Brown Scientist Public Health Ontario Assistant Professor University of Toronto Adjunct Scientist ICES

Ontario Lab Information System Currently Covers 2007 to Fall 2015 2,892 unique test result types 202 Ontario labs 1 billion test orders 2.2 billion test results

Text result field Comment:\.br\The presence of C. difficile DNA is not diagnostic of\.br\infection and should be interpreted in conjunction with\.br\clinical presentation.\.br\ \.br\ Duplicate specimens received within 7 days of a NEGATIVE\.br\test or within 14 days of a POSITIVE test will be rejected. C. difficile Cytotoxin (PCR) Positive by RT PCR\.br\ **Infection Control Additional Precautions - Contact**\.br\ \.br\ \.br\ Phoned to (416) 123-4567 \.br\ Date: Apr 3,2015 \.br\ At: 14:10\.br\ By: John Doe

COMBAT-AMR Comprehensive Ontario Microbiology LaBoratory Administrative data for AntiMicrobial Resistance The stated purpose was to: Identify incidence and prevalence of AMR Measure the attributable mortality of each AMR Combine into Clinical Antimicrobial Resistance Index

Objective Identify tests of interest Code test results Describe test results Validate

Identify ICES provided us with a table of LOINC codes Logical Observation Identifiers Names and Codes A description of a microbiology result field LOINC -- Type C = Culture Test S = Susceptibility Test OST = Organism Specific Test LOINC -- Priority 1 = definitely of interest. 6 = definitely not of interest

Identify LOINC loincfullyspecifiedname frequency 05-Dec AMIKACIN:SUSC:PT:ISOLATE:ORDQN:MIC 3201 10138-6 T' wave amplitude.lead V3:Elpot:Pt:Heart:Qn:EKG 124 10219-4 Surgical operation note preoperative Dx:Imp:Pt:Patient:Nar 13646 10328-3 Lymphocytes/100 leukocytes:nfr:pt:csf:qn:manual count 5286 10329-1 Monocytes/100 leukocytes:nfr:pt:csf:qn:manual count 1145 10330-9 Monocytes/100 leukocytes:nfr:pt:body fld:qn:manual count 5227 10334-1 CANCER AG 125:ACNC:PT:SER/PLAS:QN 270790 10346-5 Hemoglobin A:ACnc:Pt:Bld:Qn:Electrophoresis 1437 10352-3 Bacteria identified:prid:pt:gen:nom:aerobic culture 4503 10353-1 Bacteria identified:prid:pt:nose:nom:aerobic culture 1541 10355-6 MICROSCOPIC OBSERVATION:PRID:PT:BONE MAR:NOM:WRIGHT GIEMSA STAIN 1413 10357-2 MICROSCOPIC OBSERVATION:PRID:PT:WND:NOM:GRAM STAIN 80150 10434-9 COMPLEMENT C3 AG:ACNC:PT:TISS:ORD:IMMUNE STAIN 3157 10466-1 ANION GAP 3:SCNC:PT:SER/PLAS:QN 1624478 10488-5 IGA AG:ACNC:PT:TISS:ORD:IMMUNE STAIN 3156 10491-9 IGG AG:ACNC:PT:TISS:ORD:IMMUNE STAIN 3156 10493-5 IGM AG:ACNC:PT:TISS:ORD:IMMUNE STAIN 3156 10501-5 LUTROPIN:ACNC:PT:SER/PLAS:QN 890065 10524-7 Microscopic observation:prid:pt:cvx:nom:cyto stain 31989 10525-4 MICROSCOPIC OBSERVATION:PRID:PT:XXX:NOM:CYTO STAIN 313922

Identify LOINC loincfullyspecifiedname frequency priority testype 634-6 BACTERIA IDENTIFIED:PRID:PT:XXX:NOM:AEROBIC CULTURE 9216722 1 C 6463-4 BACTERIA IDENTIFIED:PRID:PT:XXX:NOM:CULTURE 7087153 1 C 43409-2 BACTERIA IDENTIFIED:PRID:PT:ISOLATE:NOM:CULTURE 2167222 1 C 626-2 BACTERIA IDENTIFIED:PRID:PT:THRT:NOM:CULTURE 1246629 1 C 630-4 BACTERIA IDENTIFIED:PRID:PT:URINE:NOM:CULTURE 940225 1 C 600-7 BACTERIA IDENTIFIED:PRID:PT:BLD:NOM:CULTURE 673178 1 C 625-4 BACTERIA IDENTIFIED:PRID:PT:STOOL:NOM:CULTURE 294157 1 C 17928-3 Bacteria identified:prid:pt:bld:nom:aerobic culture 284073 1 C 18998-5 TRIMETHOPRIM+SULFAMETHOXAZOLE:SUSC:PT:ISOLATE:ORDQN 2552324 1 S 18955-5 NITROFURANTOIN:SUSC:PT:ISOLATE:ORDQN 2409756 1 S 18928-2 GENTAMICIN:SUSC:PT:ISOLATE:ORDQN 2391134 1 S 18906-8 CIPROFLOXACIN:SUSC:PT:ISOLATE:ORDQN 2324269 1 S 18864-9 AMPICILLIN:SUSC:PT:ISOLATE:ORDQN 2211872 1 S 18900-1 CEPHALOTHIN:SUSC:PT:ISOLATE:ORDQN 1572324 1 S 18878-9 CEFAZOLIN:SUSC:PT:ISOLATE:ORDQN 1173398 1 S

Identify Culture Tests N = 40 Priority 1 LOINCs Susceptibility Tests N = 197 Priority 1 LOINCs

Describe Culture Tests 4,552,482 test result records in 2014 63,312 unique values 1 every 70 records are unique Susceptibility Tests 3,823,864 test result records in 2014 2,217 unique values 1 out of 1700 records are unique Complexity Culture tests are 25X more complex

Coding Culture Tests List of 70 organisms (e. coli, staph aureus, etc) Multiple organisms Not classified Susceptibility Tests Susceptible Intermediate Resistant Other (MIC values, etc) Not classified

Coding Rule-based NLP (using regular expressions) Traditional Machine Learning Deep learning

Regular Expressions Character groups Any character =. Class of characters = [] E.g. lowercase letters [a-z], numbers [0-9], etc. Repetition? (absent or once) * (absent or any number) + (at least once) Concatenation = implicit or () ab = (a)(b) Alternation (OR statement) = 15

Regular Expressions R: uses POSIX standard grep(regexp, textvector) returns position grepl(regexp, textvector) whether or not it exists grepl( e.coli, DESCRIPTION) SAS (within a data step): uses Perl standard PRXPARSE compiles the regular expression PRXMATCH finds the position of the pattern match PRXMATCH(PRXPARSE('/e.coli/'), textvariable) > 0 16

Describing C & S coding This is a first pass 1. C coding 2. S coding 3. S x antibiotic

Describe C Organism N % No growth 976,245 21.4 Escherichia coli 525,543 11.5 Neisseria gonorrhoeae 263,926 5.8 Enterococcus sp. 149,788 3.3 Staphyloccocus aureus 98,662 2.2 Klebsiella sp. 71,812 1.6 Enterococcus faecalis 63,852 1.4 Campylobacter sp. 52,292 1.1 Klebsiella pneumoniae 49,041 1.1 Shigella sp. 48,814 1.1 Yersinia sp. 47,199 1 * Note 2.54 million coded records ~ 55.7% coded

Describe S Result N % Susceptible 2,802,758 73.3 Resistant 707,113 18.5 Intermediate 187,274 4.9 Other 117,366 3.1 Not classified 9,353 0.2 Total 3,823,864

Describe S x Antibiotic LOINC Antibiotic S I R %R Total 18998-5 TMP-SMX 415931 191 95954 18.7 512076 18955-5 Nitrofurantoin 389517 45470 50235 10.4 485222 18906-8 Ciprofloxacin 388648 7526 79949 16.8 476123 18928-2 Gentamicin 437798 3819 33263 7 474880 18864-9 Ampicillin 189159 4456 182741 48.6 376356 18900-1 Cephalothin 132223 71047 61366 23.2 264636 18878-9 Cefazolin 152923 5825 45233 22.2 203981 18996-9 Tobramycin 157200 14658 10370 5.7 182228 18862-3 Amoxiclav 86721 21391 19879 15.5 127991 18895-3 Ceftriaxone 77484 278 14776 16 92538 18880-5 Cefixime 46449 1382 5080 9.6 52911

Cleaning OLIS microbiology data 2-pronged approach Quick and dirty approach Subset of data we suspect (apriori) will be clean Outpatient urine cultures Rule-based NLP Sustainable approach Comprehensive Deep learning Active learning

Conclusions Susceptibility tests are easy to code we can probably do with rule-based NLP Culture tests will be more difficult to code and will require more sophisticated NLP methods